Neuburgh Advisers’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,360
Closed -$62K 885
2018
Q1
$62K Buy
+1,360
New +$62K ﹤0.01% 838